Elevance Health logo

Elevance Health Share Price (NYSE: ELV)

$318.11

7.7

(2.48%)

Live

Last updated on

Check the interactive Elevance Health Stock chart to analyse performance

Elevance Health stock performance

as on August 30, 2025 at 12:42 am IST

  • Today's Low:$312.30
    Today's High:$320.00

    Day's Volatility :2.41%

  • 52 Weeks Low:$273.71
    52 Weeks High:$567.26

    52 Weeks Volatility :51.75%

Elevance Health Stock Returns

PeriodElevance Health, IncSector (Health Care)Index (Russel 2000)
3 Months
-19.14%
3.1%
0.0%
6 Months
-21.8%
-8.4%
0.0%
1 Year
-43.78%
-12.6%
0.0%
3 Years
-36.25%
7.9%
-6.1%

Elevance Health, Inc Key Stats

Check Elevance Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$310.41
Open
$307.41
Today's High
$320.0
Today's Low
$312.3
Market Capitalization
$69.8B
Today's Volume
$1.2M
52 Week High
$567.26
52 Week Low
$273.71
Revenue TTM
$189.3B
EBITDA
$9.5B
Earnings Per Share (EPS)
$23.58
PE Ratio
13.14
Dividend Yield
2.15%
Profit Margin
2.83%
Quarterly Earnings Growth YOY
-0.22%
Return On Equity TTM
12.42%

Stock Returns calculator for Elevance Health Stock including INR - Dollar returns

The Elevance Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Elevance Health investment value today

Current value as on today

₹62,939

Returns

₹37,061

(-37.06%)

Returns from Elevance Health Stock

₹42,381 (-42.38%)

Dollar Returns*

₹5,319 (+5.32%)

Indian investors sentiment towards Elevance Health Stock

-59.82%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Investment in Elevance Health Shares from India has dropped by -59.82% over the past 30 days, indicating reduced transactional activity.

-16%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Elevance Health Stock from India on INDmoney has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Elevance Health Stock

NameShares HeldChange in Shares% of Assets
Nippon India US Equity Opportunities Fund Direct Growth logo
7071
96.02
2.48%
Motilal Oswal S&P 500 Index Fund Direct Growth logo
1826
-8.18
0.12%

Global Institutional Holdings in Elevance Health, Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    10.15%

  • BlackRock Inc

    9.46%

  • State Street Corp

    4.73%

  • T. Rowe Price Associates, Inc.

    3.59%

  • Capital Research & Mgmt Co - Division 3

    2.88%

  • Wellington Management Company LLP

    2.81%

Analyst Recommendation on Elevance Health Stock

Rating
Trend

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 26 Wall street analysts offering stock ratings for Elevance Health(by analysts ranked 0 to 5 stars)

Elevance Health Share Price Target

What analysts predicted

Upside of 15.82%

Target:

$368.44

Current:

$318.11

Elevance Health share price target is $368.44, a slight Upside of 15.82% compared to current price of $318.11 as per analysts' prediction.

Elevance Health Stock Insights

  • Price Movement

    In the last 3 months, ELV stock has moved down by -18.4%
  • Increasing Revenue

    Elevance Health, Inc. has demonstrated consistent revenue growth over the last six quarters. The company's revenue increased from $42.57 billion to $49.77 billion, averaging an increase of 3.1% per quarter.
  • Decreasing Net Profit

    Elevance Health, Inc. has experienced a decline in its net profit over the last two quarters. In the first quarter, the net profit was $2.18 billion, which decreased to $1.74 billion in the second quarter. This represents an average decrease of 20.2% per quarter.
  • ELV vs CVS (1 yr)

    In the last 1 year, Cvs Health Corporation has given 26.6% return, outperforming this stock by 70.4%
  • ELV vs CI (3 yr)

    In the last 3 years, Elevance Health, Inc has experienced a drawdown of -36.5%, however The Cigna Corp resisted the overall trend and outperformed by 8.4%
  • Price to Sales

    Elevance Health, Inc is currently valued at a Price-to-Sales Ratio of $0.4, meaning that investors are willing to pay $0.4 for every $1 of sales generated by the company. In comparison, CVS Health Corporation has a lower Price-to-Sales Ratio of $0.2, indicating that investors value their sales less. This suggests that Elevance Health is perceived more favorably in terms of its sales performance compared to CVS Health.

Elevance Health, Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$176.8B
↑ 3.19%
Net Income
$6.0B
↓ 0.12%
Net Profit Margin
3.38%
↓ 0.11%

Elevance Health Technicals Summary

Sell

Neutral

Buy

Elevance Health is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Elevance Health, Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Elevance Health, Inc logo
5.73%
-21.8%
-43.78%
-36.25%
10.25%
The Cigna Corp logo
0.37%
-3.2%
-17.2%
4.87%
68.55%
Cvs Health Corporation logo
15.76%
9.74%
26.59%
-27.0%
16.1%
Humana Inc. logo
13.98%
10.21%
-15.18%
-38.63%
-28.21%
Unitedhealth Group Incorporated logo
13.63%
-36.35%
-48.9%
-42.18%
-3.28%

Elevance Health Dividend announcements

  • Elevance Health Dividends September, 2025

    In the quarter ending September,2025. Elevance Health has declared dividend of $1.71

About Elevance Health, Inc

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Organization
Elevance Health
Employees
104200
CEO
Ms. Gail Koziara Boudreaux
Industry
Healthcare

Key Management of Elevance Health, Inc

NameTitle
Ms. Gail Koziara Boudreaux
President, CEO & Director
Mr. Mark Bradley Kaye
Executive VP & CFO
Mr. Peter David Haytaian Esq.
Executive VP and President of Carelon & CarelonRx
Mr. Charles Morgan Kendrick Jr.
Executive VP & President of Commercial Health Benefits
Ms. Felicia Farr Norwood
Executive VP & President of Government Health Benefits
Mr. Scott Wayne Anglin
SVP, Treasurer & Chief Investment Officer
Mr. Ronald William Penczek
Senior VP, Controller & Chief Accounting Officer
Mr. Blair Williams Todt
Executive VP and Chief Legal & Administrative Officer
Mr. Nathan Allen Rich
Vice President of Investor Relations
Ms. Julie Goon
Senior Vice President of Public Affairs

Important FAQs about investing in ELV Stock from India :

What is Elevance Health share price today?

Elevance Health share price today is $318.11 as on . Elevance Health share today touched a day high of $320.00 and a low of $312.30.

What is the 52 week high and 52 week low for Elevance Health share?

Elevance Health share touched a 52 week high of $567.26 and a 52 week low of $273.71. Elevance Health stock price today i.e. is trending at $318.11, lower by 43.92% versus the 52 week high.

How to invest in Elevance Health Stock (ELV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Elevance Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elevance Health Shares that will get you 0.0047 shares as per Elevance Health share price of $318.11 per share as on August 30, 2025 at 12:42 am IST.

What is the minimum amount required to buy Elevance Health Stock (ELV) from India?

Indian investors can start investing in Elevance Health (ELV) shares with as little as ₹88.286 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Elevance Health stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Elevance Health share’s latest price of $318.11 as on August 30, 2025 at 12:42 am IST, you will get 0.0314 shares of Elevance Health. Learn more about fractional shares .

What are the returns that Elevance Health has given to Indian investors in the last 5 years?

Elevance Health stock has given 10.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?